APOA5 gene polymorphism assessment and association with hypertriglyceridemia in the military force of the State of Goiás

Authors

DOI:

https://doi.org/10.33448/rsd-v10i7.16229

Keywords:

Polymorphism; APOA5; Dyslipidemias.

Abstract

According to the World Health Organization (WHO), dyslipidemias are determinant for the onset of cardiovascular diseases and represent more than 30% of global deaths. Changes in serum lipid levels are a direct consequence of dyslipidemia.   This study aimed to verify the relationship between genetic polymorphism APOA5  and dyslipidemia. This is a case-control study with 199 officers of the military force of the state of Goiás in which the relationship between lipid profile and genetic polymorphism rs964184 was evaluated. Real-time Polymerase Chain Reaction (real-time PCR) was used to identify genetic polymorphism rs964184. Of the participants analyzed, 93% were male and 7% female, the lipid profile showed that 115 participants had dyslipidemia (group of cases) and 84 were within the reference range (control group). The genetic polymorphism rs964184 of the case group showed that 64.3% (74/115) of the participants had genotype CC, 33.0% (38/115) had cg genotype and 2.6% (3/115) had GG genotype. In the control group, 69.0% (58/84) had genotype CC, 27.4% (23/84) had cg genotype, 3.6% (3/84) had GG genotype. In conclusion, the G alllea is related to high levels of triglycerides (≥ 150 mg/dL) and the C allea is related to normal HDL cholesterol levels (≥ 40 mg/dL). Therefore, homozygous (GG) or heterozygous (CG) individuals are more inclined to have high triglycerides and low HDL cholesterol levels, which are associated with an increased risk of developing cardiovascular disease.

References

Andrade, F. M. & Hutz, M. H. (2002). O componente genético da determinação dos lipídeos séricos. Ciênc. Saúde Coletiva 7, 175-82. https://doi.org/10.1590/S1413-81232002000100016

ANVISA (2011). Dislipidemia. Saúde e Economia 3(6): 1-4 (3)

Demirag, M.D., Onen, H.I., Karaoguz, M.Y. et al. (2007). Apolipoprotein E Gene Polymorphism in Nonalcoholic Fatty Liver Disease. Dig Dis Sci 52, 3399–3403. https://doi.org/10.1007/s10620-007-9740-5

Fu Q, Tang X, Chen J, Su L, et al. (2015). Effects of Polymorphisms in APOA4-APOA5-ZNF259-BUD13 Gene Cluster on Plasma Levels of Triglycerides and Risk of Coronary Heart Disease in a Chinese Han Population. PLoS One. 10(9): e0138652.

Garcez MR., Pereira JL., Fontanelli MM., Marchioni DML., et al. (2014). Prevalence of Dyslipidemia According to the Nutritional Status in a Representative Sample of São Paulo. Arq. Bras. Cardiol. 103(6): 476–484.

Hagberg JM, Wilund KR, Ferrell RE. (2000). APO E gene and gene-environment effects on plasma lipoprotein-lipid levels. Physiol Genomics.4(2):101-108. Published 2000 Dec 18. doi:10.1152/physiolgenomics.2000.4.2.101

Loures DL, Sant'Anna I, Baldotto CSR da, et al. (2002). Estresse Mental e Sistema Cardiovascular. Arq. Bras. Cardiol.7: 525-530. http://dx.doi.org/10.1590/S0066-782X2002000500012

Mirhafez SR, Avan A, Pasdar A, Khatamianfar S, et al. (2016) Zinc Finger 259 Gene Polymorphism rs964184 is Associated with Serum Triglyceride Levels and Metabolic Syndrome. Int. J. Mol. Cell. Med. 5(1):8‐18.

Moreira RO, Santos RD, Martinez L, Saldanha FC, Pimenta JLAC, et al. (2006). Perfil lipídico de pacientes com alto risco para eventos cardiovasculares na prática clínica diária. Arq. Bras. Endocrinol. Metab. 50(3): 481-489.

Novak EM e Bydlowski SP (1996). Biologia Molecular das Dislipidemias. Variação Genética das Apolipoproteínas. Arq. Bras. Cardiol. 67(6): 411-417.

Nyberg ST, Fransson EI, Heikkilä K, et al. (2013). Job strain and cardiovascular disease risk factors: meta-analysis of individual-participant data from 47,000 men and women. PLoS One.8(6):e67323. Published 2013 Jun 20. doi:10.1371/journal.pone.0067323

Parra EJ, Mazurek A, Gignoux CR, Sockell A, et al. (2017). Admixture mapping in two Mexican samples identifies significant associations of locus ancestry with triglyceride levels in the BUD13/ZNF259/APOA5 region and fine mapping points to rs964184 as the main driver of the association signal. PLoS One. 12(2): e0172880.

SBC – Sociedade Brasileira de Cardiologia (2017). Atualização da diretriz brasileira de dislipidemias e prevenção da aterosclerose. Arq. Bras. Cardiol.109(1): 76.

Tóth PP, Potter D, Ming EE (2012). Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003–2006. J. Clin. Lipidol. 6(4): 325-330.

Van der Vliet HN, Sammels MG, Leegwater AC, Levels JH, et al. (2001). A Novel Apolipoprotein Associated with an Early Phase of Liver Regeneration. J. Biol. Chem. 276: 44512–44520.

Van de Woestijne AP, van der Graaf Y, de Bakker PI, Asselbergs FW et al. (2014). Rs964184 (APOA5-A4-C3-A1) Is Related to Elevated Plasma Triglyceride Levels, but Not to an Increased Risk for Vascular Events in Patients with Clinically Manifest Vascular Disease. PLoS One. 9(6): e101082.

WHO (2017). Cardiovascular diseases (CVDs). Disponível em [https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)].

WHO (2017). Cardiovascular diseases (CVDs). Disponível em [https://www.who.int/health-topics/cardiovascular-diseases/#tab=tab_1].

Xia J, Cai W, Peng C. (2015) Association of APOA5 T1131C polymorphism and risk of coronary artery disease. Int. J. Clin. Exp. Med. 8(6):8986‐8994.

Xu X, Li Y, Huang Y, Ye H, et al. (2018). Impact of gender and age on the association of the BUD13-ZNF259 rs964184 polymorphism with coronary heart disease. Anatol. J. Cardiol. 19(1): 42-49.

Zhang LX, Sun Y, Liang Y, Li K, et al. (2012). Relationship between dyslipidemia and gene polymorphism in Tibetan population. Biomed. Environ. Sci. 25(3): 305-10.

Zhang X, Qi Q, Bray GA, Hu FB, Sacks FM, et al. (2012). APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: The Pounds Lost Trial. Am. J. Clin. Nutr. 96(4): 917‐922.

Downloads

Published

14/06/2021

How to Cite

SILVA, R. dos R. F.; NASCIMENTO, T. L. de; SILVA, A. M. T. C.; COSTA, S. H. N.; CASTRO, F. S.; SILVA, M. A. C.; CUNHA, L. C. . APOA5 gene polymorphism assessment and association with hypertriglyceridemia in the military force of the State of Goiás. Research, Society and Development, [S. l.], v. 10, n. 7, p. e8410716229, 2021. DOI: 10.33448/rsd-v10i7.16229. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/16229. Acesso em: 26 nov. 2024.

Issue

Vol. 10 No. 7

Section

Health Sciences

License

Copyright (c) 2021 Raphael dos Reis Frazao Silva; Tiago Lemos de Nascimento; Antonio Marcio Teodoro Cordeiro Silva; Sergio Henrique Nascente Costa; Frank Sousa Castro; Marina Alves Coelho Silva; Luiz Carlos Cunha

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.